New alternatives for laser vaporization of the prostate: Experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device

World Journal of Urology

Volumn 28, Issue 2, 2010, Pages 181-186

  Wezel, Felix ^a   Wendt Nordahl, Gunnar ^b   Huck, Nina ^a   Bach, Thorsten ^a   Weiss, Christel ^c   Michel, Maurice Stephan ^a   Häcker, Axel ^a  

^a Uinversity Medical Center Mannheim   (Germany)

^b Hospital Sindelfingen Böblingen   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Benign prostatic enlargement; Diode laser; KTP laser; Minimal invasive; TURP

Indexed keywords

ANIMAL; ARTICLE; BLEEDING; COMPARATIVE STUDY; DIODE LASER; HEMOSTASIS; INSTRUMENTATION; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; MINIMALLY INVASIVE SURGERY; NECROSIS; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROSTATE; PROSTATE HYPERTROPHY; SWINE; TRANSURETHRAL RESECTION;

ANIMALS; BLOOD LOSS, SURGICAL; HEMOSTASIS; LASER THERAPY; LASERS, SEMICONDUCTOR; MALE; NECROSIS; POSTOPERATIVE COMPLICATIONS; PROSTATE; PROSTATIC HYPERPLASIA; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SWINE; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 77952089413     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0499-5     Document Type: Article

References (26)

1. Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int 83(3): 227-237.
2. Rassweiler J et al (2006) Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50(5): 969-979 discussion 980.
3. Madersbacher S et al (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46(5): 547-554.
4. Fried NM (2007) New laser treatment approaches for benign prostatic hyperplasia. Curr Urol Rep 8(1): 47-52.
5. Kuntz RM (2007) Laser treatment of benign prostatic hyperplasia. World J Urol 25(3): 241-247.
6. Bachmann A et al (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48(6): 965-971 discussion 972.
7. Hai MA (2009) Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 73(4): 807-810.
8. Gomez Sancha F et al (2007) Photoselective vaporization of the prostate (GreenLight PV): lessons learnt after 3500 procedures. Prostate Cancer Prostatic Dis 10(4): 316-322.
9. Wendt-Nordahl G et al (2007) 980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol 52(6): 1723-17238.
10. Michel MS et al (1996) Rotoresect: new technique for resection of the prostate: experimental phase. J Endourol 10(5): 473-478.
11. Wendt-Nordahl G et al (2008) Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22(5): 1041-1045.
12. Reich O et al (2004) Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 171(6 Pt 1): 2502-2504.
13. Gilling P (2008) Holmium laser enucleation of the prostate (HoLEP). BJU Int 101(1): 131-142.
14. Malek RS, Barrett DM, Kuntzman RS (1998) High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 h later. Urology 51(2): 254-256.
15. Bouchier-Hayes DM et al (2006) KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 20(8): 580-585.
16. Sandhu JS et al (2004) High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64(6): 1155-1159.
17. Malek RS et al (2009) Greenlight photoselective 120-Watt 532-nm lithium triborate laser vaporization prostatectomy in living canines. J Endourol.
18. Woo H et al (2008) Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (≥80 ml). Eur Urol Suppl 7(4): 378-383.
19. Leonardi R (2009) Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis.
20. Seitz M et al (2009) Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations. BJU Int 103(6): 770-775.
21. Seitz M et al (2008) Ex vivo and in vivo investigations of the novel 1, 470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci.
22. Costello AJ et al (1992) Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 69(6): 603-608.
23. Ruszat R et al (2009) Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int.
24. Erol A et al (2009) High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol 182(3): 1078-1082.
25. Seitz M et al (2007) The diode laser: a novel side-firing approach for laser vaporisation of the human prostate-immediate efficacy and 1-year follow-up. Eur Urol 52(6): 1717-1722.
26. Kang HW et al (2008) Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol 180(6): 2675-2680.